{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:33:33Z","timestamp":1794346413240,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["930"],"award-info":[{"award-number":["930"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11033-021-06567-8","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T02:02:16Z","timestamp":1627178536000},"page":"5519-5529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls"],"prefix":"10.1007","volume":"48","author":[{"given":"Samaneh","family":"Ostadmohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Azimirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirjalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7581","authenticated-orcid":false,"given":"Abbas","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9580-2676","authenticated-orcid":false,"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Asadzadeh Aghdaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,25]]},"reference":[{"issue":"9904","key":"6567_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet (London, England) 382(9904):1587\u20131599","journal-title":"Lancet (London, England)"},{"issue":"10","key":"6567_CR2","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","volume":"67","author":"EM de Vries","year":"2018","unstructured":"de Vries EM, Wang J, Williamson KD, Leeflang MM, Boonstra K, Weersma RK, Beuers U, Chapman RW, Geskus RB, Ponsioen CY (2018) A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut 67(10):1864\u20131869","journal-title":"Gut"},{"issue":"6","key":"6567_CR3","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ, Tuynman HA et al (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology (Baltimore, MD) 58(6):2045\u20132055","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"3","key":"6567_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD (2013) Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 145(3):521\u2013536","journal-title":"Gastroenterology"},{"issue":"5 Pt 1","key":"6567_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","volume":"100","author":"R Olsson","year":"1991","unstructured":"Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S (1991) Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 100(5 Pt 1):1319\u20131323","journal-title":"Gastroenterology"},{"issue":"5","key":"6567_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 56(5):1181\u20131188","journal-title":"J Hepatol"},{"issue":"4","key":"6567_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","volume":"10","author":"A O'Toole","year":"2012","unstructured":"O\u2019Toole A, Alakkari A, Keegan D, Doherty G, Mulcahy H, O\u2019Donoghue D (2012) Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol 10(4):439\u2013441","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"6567_CR8","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1002\/ibd.22938","volume":"18","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, Tuynman HA, Beuers U, Ponsioen CY (2012) Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis 18(12):2270\u20132276","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"6567_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ng.2616","volume":"45","author":"JZ Liu","year":"2013","unstructured":"Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weism\u00fcller TJ, Eksteen B et al (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45(6):670\u2013675","journal-title":"Nat Genet"},{"issue":"3","key":"6567_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/ecco-jcc\/jjv204","volume":"10","author":"D Kevans","year":"2016","unstructured":"Kevans D, Tyler AD, Holm K, Jorgensen KK, Vatn MH, Karlsen TH, Kaplan GG, Eksteen B, Gevers D, Hov JR et al (2016) Characterization of intestinal microbiota in ulcerative colitis patients with and without primary sclerosing cholangitis. J Crohns Colitis 10(3):330\u2013337","journal-title":"J Crohns Colitis"},{"issue":"4","key":"6567_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/hep.1840130425","volume":"13","author":"SN Lichtman","year":"1991","unstructured":"Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB (1991) Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology (Baltimore, MD) 13(4):766\u2013772","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"6567_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.12232","volume":"37","author":"JH Tabibian","year":"2013","unstructured":"Tabibian JH, Weeding E, Jorgensen RA, Petz JL, Keach JC, Talwalkar JA, Lindor KD (2013) Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014a pilot study. Aliment Pharmacol Ther 37(6):604\u2013612","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"6567_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep.20457","volume":"40","author":"M Farkkila","year":"2004","unstructured":"Farkkila M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, Karkkainen P (2004) Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology (Baltimore, MD) 40(6):1379\u20131386","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"6567_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010) Diagnosis and management of primary sclerosing cholangitis. Hepatology (Baltimore, MD) 51(2):660\u2013678","journal-title":"Hepatology (Baltimore, MD)"},{"key":"6567_CR15","doi-asserted-by":"crossref","unstructured":"Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol 170:2\u20136; discussion 16\u201319","DOI":"10.3109\/00365528909091339"},{"issue":"7","key":"6567_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","volume":"75","author":"WR Kim","year":"2000","unstructured":"Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER (2000) A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc 75(7):688\u2013694","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6567_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.mimet.2011.06.010","volume":"86","author":"T Bacchetti De Gregoris","year":"2011","unstructured":"Bacchetti De Gregoris T, Aldred N, Clare AS, Burgess JG (2011) Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods 86(3):351\u2013356","journal-title":"J Microbiol Methods"},{"issue":"4","key":"6567_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","volume":"66","author":"M Kummen","year":"2017","unstructured":"Kummen M, Holm K, Anmarkrud JA, Nyg\u00e5rd S, Vesterhus M, H\u00f8ivik ML, Tr\u00f8seid M, Marschall HU, Schrumpf E, Moum B et al (2017) The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut 66(4):611\u2013619","journal-title":"Gut"},{"issue":"4","key":"6567_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ecco-jcc\/jju023","volume":"9","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, Boonstra K, D\u2019Haens GR, Heilig HG, Zoetendal EG, de Vos WM, Ponsioen CY (2015) The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. J Crohns Colitis 9(4):342\u2013348","journal-title":"J Crohns Colitis"},{"issue":"10","key":"6567_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","volume":"65","author":"J Sabino","year":"2016","unstructured":"Sabino J, Vieira-Silva S, Machiels K, Joossens M, Falony G, Ballet V, Ferrante M, Van Assche G, Van der Merwe S, Vermeire S et al (2016) Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut 65(10):1681\u20131689","journal-title":"Gut"},{"issue":"1","key":"6567_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-018-0515-8","volume":"10","author":"R Kolde","year":"2018","unstructured":"Kolde R, Franzosa EA, Rahnavard G, Hall AB, Vlamakis H, Stevens C, Daly MJ, Xavier RJ, Huttenhower C (2018) Host genetic variation and its microbiome interactions within the Human Microbiome Project. Genome Med 10(1):6\u20136","journal-title":"Genome Med"},{"key":"6567_CR22","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3389\/fmicb.2017.01162","volume":"8","author":"VK Gupta","year":"2017","unstructured":"Gupta VK, Paul S, Dutta C (2017) Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Microbiol 8:1162","journal-title":"Front Microbiol"},{"issue":"3","key":"6567_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N et al (2019) Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol 4(3):492\u2013503","journal-title":"Nat Microbiol"},{"issue":"3","key":"6567_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","volume":"67","author":"R Tang","year":"2018","unstructured":"Tang R, Wei Y, Li Y, Chen W, Chen H, Wang Q, Yang F, Miao Q, Xiao X, Zhang H et al (2018) Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67(3):534\u2013541","journal-title":"Gut"},{"issue":"5","key":"6567_CR25","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/infdis\/157.5.1032","volume":"157","author":"EK Steffen","year":"1988","unstructured":"Steffen EK, Berg RD, Deitch EA (1988) Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 157(5):1032\u20131038","journal-title":"J Infect Dis"},{"issue":"5","key":"6567_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/bjs.1800670509","volume":"67","author":"FR Jackaman","year":"1980","unstructured":"Jackaman FR, Hilson GR, Smith L (1980) Bile bacteria in patients with benign bile duct stricture. Br J Surg 67(5):329\u2013332","journal-title":"Br J Surg"},{"issue":"5","key":"6567_CR27","first-page":"316","volume":"52","author":"AC Maddocks","year":"1973","unstructured":"Maddocks AC, Hilson GR, Taylor R (1973) The bacteriology of the obstructed biliary tree. Ann R Coll Surg Engl 52(5):316\u2013319","journal-title":"Ann R Coll Surg Engl"},{"issue":"6","key":"6567_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0016-5107(02)70365-9","volume":"56","author":"R Rerknimitr","year":"2002","unstructured":"Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S (2002) Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc 56(6):885\u2013889","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"6567_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","volume":"18","author":"J Pohl","year":"2006","unstructured":"Pohl J, Ring A, Stremmel W, Stiehl A (2006) The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 18(1):69\u201374","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"6567_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/jgh.15260","volume":"36","author":"B Nadalian","year":"2021","unstructured":"Nadalian B, Yadegar A, Houri H, Olfatifar M, Shahrokh S, Asadzadeh Aghdaei H, Suzuki H, Zali MR (2021) Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis. J Gastroenterol Hepatol 36(4):852\u2013863","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"6567_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K et al (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63(8):1275\u20131283","journal-title":"Gut"},{"issue":"21","key":"6567_CR32","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","volume":"26","author":"R Little","year":"2020","unstructured":"Little R, Wine E, Kamath BM, Griffiths AM, Ricciuto A (2020) Gut microbiome in primary sclerosing cholangitis: a review. World J Gastroenterol 26(21):2768\u20132780","journal-title":"World J Gastroenterol"},{"issue":"1","key":"6567_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/0971-5916.162091","volume":"142","author":"J Kabeerdoss","year":"2015","unstructured":"Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS (2015) Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J Med Res 142(1):23\u201332","journal-title":"Indian J Med Res"},{"issue":"8","key":"6567_CR34","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/ibd.20903","volume":"15","author":"H Sokol","year":"2009","unstructured":"Sokol H, Seksik P, Furet J, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Dor\u00e9 J (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15(8):1183\u20131189","journal-title":"Inflamm Bowel Dis"},{"issue":"9904","key":"6567_CR35","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. Lancet 382(9904):1587\u20131599","journal-title":"Lancet"},{"key":"6567_CR36","doi-asserted-by":"publisher","first-page":"6787269","DOI":"10.1155\/2016\/6787269","volume":"2016","author":"JG de Moraes","year":"2016","unstructured":"de Moraes JG, Motta MEFA, Beltr\u00e3o MFS, Salviano TL, da Silva GAP (2016) Fecal microbiota and diet of children with chronic constipation. Int J Pediatr 2016:6787269\u20136787269","journal-title":"Int J Pediatr"},{"issue":"19","key":"6567_CR37","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.1128\/AEM.01906-15","volume":"81","author":"YW Yang","year":"2015","unstructured":"Yang YW, Chen MK, Yang BY, Huang XJ, Zhang XR, He LQ, Zhang J, Hua ZC (2015) Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in mouse feces. Appl Environ Microbiol 81(19):6749\u20136756","journal-title":"Appl Environ Microbiol"},{"key":"6567_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/1471-2164-14-788","volume":"14","author":"ML Hermann-Bank","year":"2013","unstructured":"Hermann-Bank ML, Skovgaard K, Stockmarr A, Larsen N, M\u00f8lbak L (2013) The Gut Microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity. BMC Genomics 14:788","journal-title":"BMC Genomics"},{"issue":"11","key":"6567_CR39","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1128\/AEM.68.11.5445-5451.2002","volume":"68","author":"T Matsuki","year":"2002","unstructured":"Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68(11):5445\u20135451","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"6567_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ijhydene.2007.09.037","volume":"33","author":"C-H Hung","year":"2008","unstructured":"Hung C-H, Cheng C-H, Cheng L-H, Liang C-M, Lin C-Y (2008) Application of Clostridium-specific PCR primers on the analysis of dark fermentation hydrogen-producing bacterial community. Int J Hydrogen Energy 33(5):1586\u20131592","journal-title":"Int J Hydrogen Energy"},{"issue":"4","key":"6567_CR41","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/AEM.05605-11","volume":"78","author":"IK Wang","year":"2012","unstructured":"Wang IK, Lai H-C, Yu C-J, Liang C-C, Chang C-T, Kuo H-L, Yang Y-F, Lin C-C, Lin H-H, Liu Y-L et al (2012) Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients. Appl Environ Microbiol 78(4):1107","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"6567_CR42","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1128\/JCM.39.7.2541-2547.2001","volume":"39","author":"F Martineau","year":"2001","unstructured":"Martineau F, Picard FJ, Ke D, Paradis S, Roy PH, Ouellette M, Bergeron MG (2001) Development of a PCR assay for identification of Staphylococci at genus and species levels. J Clin Microbiol 39(7):2541","journal-title":"J Clin Microbiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06567-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06567-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T16:07:45Z","timestamp":1628093265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06567-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6567"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06567-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-431119\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical clearance for conducting this study was obtained from the Institutional Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases at Shahid Beheshti University of Medical Sciences (Project No. IR.SBMU.RIGLD.REC.1395.140).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study before sample collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}